HLB Pharmaceutical Co

HLB Pharmaceutical Co EBIT Margin

The EBIT Margin (Operating Margin) of HLB Pharmaceutical Co (047920.KQ) as of Oct 20, 2026 is 2.47 %. In the previous year, EBIT Margin (Operating Margin) was 0.99 % — a change of 149.10% (higher).

EBIT Margin

2.47 %

YoY

149.10%

Last updated:

EBIT Margin (Operating Margin) of HLB Pharmaceutical Co is 2025 2.47 % . EBIT Margin (Operating Margin) of HLB Pharmaceutical Co was 2024 0.99 % . It decreases by 149.10% higher compared to the previous year.

HLB Pharmaceutical Co's operating (EBIT) margin stands at 2.5%, up from 0.8% several years earlier.

The HLB Pharmaceutical Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2017
-28.06 KRW
Jan 1, 2018
-26.34 KRW
Jan 1, 2019
2.78 KRW
Jan 1, 2021
0.77 KRW
Jan 1, 2022
-5.97 KRW
Jan 1, 2023
-4.01 KRW
Jan 1, 2024
0.99 KRW
Jan 1, 2025
2.47 KRW
The HLB Pharmaceutical Co EBIT Margin history
YEAREBIT MarginYoY
2.47 %+149.10%
0.99 %-124.71%
-4.01 %-32.92%
-5.97 %-871.72%
0.77 %-72.13%
2.78 %-110.54%
-26.34 %-6.12%
-28.06 %-1,507.76%
1.99 %-136.56%
-5.45 %-315.88%
2.53 %+12,333.70%
0.02 %-74.16%
0.08 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

HLB Pharmaceutical Co Stock analysis

What does HLB Pharmaceutical Co do? HLB Pharmaceutical Co Ltd, based in Namyangju, South Korea, operates in the Health Care sector, specializing in biotechnology-based pharmaceutical manufacturing. The company, listed on 21 December 2015, employs 230 people and produces a range of products including cimetidine, rabeprazole, and L-carnitine tablets, as well as OTC and ETC drugs like gynobetadine suppositories and commissioned medications. HLB Pharmaceutical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about HLB Pharmaceutical Co stock

EBIT Margin (Operating Margin) of HLB Pharmaceutical Co is 2.47 % in 2025.

EBIT Margin (Operating Margin) of HLB Pharmaceutical Co changed from 0.99 % to 2.47 %, representing a 149.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) HLB Pharmaceutical Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s HLB Pharmaceutical Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — HLB Pharmaceutical Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — HLB Pharmaceutical Co